Refractory Anaplastic Ependymoma

MedGen UID:: 1703773
•Concept ID:: C5205652
•: Neoplastic Process

Definition

Anaplastic ependymoma that is resistant to treatment. [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVRefractory Anaplastic Ependymoma

Pathological process
- Disease
  - Neoplasm
    - Malignant neoplastic disease
      - Anaplastic cancer
        Anaplastic ependymoma
        Refractory Anaplastic Ependymoma

Professional guidelines

PubMed

Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience.

Susam-Sen H, Varan A, Bajin İ, Göçmen R, Aydın B, Yalcin B, Kurucu N, Kutluk T, Bayhan T, Akyuz C
Naunyn Schmiedebergs Arch Pharmacol 2021 Aug;394(8):1769-1777. Epub 2021 Jun 21 doi: 10.1007/s00210-021-02109-y. PMID: 34151393

Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience.

Gorsi HS, Malicki DM, Barsan V, Tumblin M, Yeh-Nayre L, Milburn M, Elster JD, Crawford JR
J Pediatr Hematol Oncol 2019 May;41(4):e235-e241. doi: 10.1097/MPH.0000000000001339. PMID: 30681550

See all (2)

Recent clinical studies

Etiology

Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study.

DE Laclos XC, Frappaz D, Ahle G, Bronnimann C, Catry-Thomas I, Joncour A, Ghiringhelli F, Vauleon E
Anticancer Res 2022 Aug;42(8):3863-3867. doi: 10.21873/anticanres.15878. PMID: 35896241

Severe Pneumonia Caused by Methicillin-Resistant Staphylococcus pseudintermedius in an Oncology Patient: Case Report and Literature Review.

Asleh M, Feinstein Y, Lazar I, Rokney A, Baum M, Sagi O, Leibovitz E, Danino D
Microb Drug Resist 2022 Feb;28(2):222-228. Epub 2021 Oct 4 doi: 10.1089/mdr.2020.0469. PMID: 34609906

Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.

Sardi I, Sanzo M, Giordano F, Sandri A, Mussa F, Donati PA, Genitori L
Oncol Rep 2008 May;19(5):1219-23. PMID: 18425379

See all (3)

Diagnosis

Severe Pneumonia Caused by Methicillin-Resistant Staphylococcus pseudintermedius in an Oncology Patient: Case Report and Literature Review.

Asleh M, Feinstein Y, Lazar I, Rokney A, Baum M, Sagi O, Leibovitz E, Danino D
Microb Drug Resist 2022 Feb;28(2):222-228. Epub 2021 Oct 4 doi: 10.1089/mdr.2020.0469. PMID: 34609906

See all (1)

Therapy

Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study.

DE Laclos XC, Frappaz D, Ahle G, Bronnimann C, Catry-Thomas I, Joncour A, Ghiringhelli F, Vauleon E
Anticancer Res 2022 Aug;42(8):3863-3867. doi: 10.21873/anticanres.15878. PMID: 35896241

Temozolomide Treatment for Pediatric Refractory Anaplastic Ependymoma with Low MGMT Protein Expression.

Komori K, Yanagisawa R, Miyairi Y, Sakashita K, Shiohara M, Fujihara I, Morita D, Nakamura T, Ogiso Y, Sano K, Shirahata M, Fukuoka K, Ichimura K, Shigeta H
Pediatr Blood Cancer 2016 Jan;63(1):152-5. Epub 2015 Aug 25 doi: 10.1002/pbc.25696. PMID: 26305586

Metronomic cyclophosphamide with cisplatin and bevacizumab: a new chemotherapeutic regimen for refractory anaplastic ependymoma.

Lorgis V, Varbedian O, Ghiringhelli F
Anticancer Res 2012 Nov;32(11):5067-70. PMID: 23155280

Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.

Sardi I, Sanzo M, Giordano F, Sandri A, Mussa F, Donati PA, Genitori L
Oncol Rep 2008 May;19(5):1219-23. PMID: 18425379

See all (4)